Clinical Trials on Norovirus Gastroenteritis

Total 5643 results

National Institute of Allergy and Infectious Diseases...

Completed

Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies

Gastroenteritis Norovirus

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Norovirus Challenge Model

Gastroenteritis Norovirus

United States
Vaxart

Completed

Phase 1 Placebo-controlled, Randomized Trial of an Adenoviral-vector Based Norovirus Vaccine

Norovirus Gastroenteritis

United States
Vaxart

Completed

Dose-Optimization Trial of VXA-G1.1-NN in Healthy Volunteers

Norovirus Gastroenteritis

United States
National Institute of Allergy and Infectious Diseases...

Withdrawn

Phase I Study to Determine the Optimal Human Challenge Dose for a Norovirus GII.4 Challenge Stock (CIN-1)

Gastroenteritis Norovirus

United States
National Institute of Allergy and Infectious Diseases...

Completed

NNITS-Nitazoxanide for Norovirus in Transplant Patients Study

Gastroenteritis Norovirus

United States
National Institute of Allergy and Infectious Diseases...

Completed

New Challenge Pool of Norwalk Virus Inoculum

Gastroenteritis Norovirus

United States
ModernaTX, Inc.

Active, not recruiting

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 49 Years of Age and 60 to 80 Years of Age.

Norovirus Acute Gastroenteritis

United States
National Vaccine and Serum Institute, China
Zhengzhou University; Lanzhou Institute of Biological Products Co., Ltd; Beijing...

Recruiting

Clinical Trial to Evaluate the Recombinant Norovirus Bivalent (GI. 1 / GII. 4) Vaccine (Hansenula Polymorpha)

Norwalk Gastroenteritis | Norovirus Infections

China
National Vaccine and Serum Institute, China
Zhengzhou University; Lanzhou Institute of Biological Products Co., Ltd; Beijing...

Completed

A Clinical Trial to Evaluate the Safety and Immunogenicity of Norovirus Bivalent Vaccine

Norwalk Gastroenteritis | Norovirus Infections

China
National Vaccine and Serum Institute, China
Lanzhou Institute of Biological Products Co., Ltd

Not yet recruiting

Phase III Clinical Trial to Evaluate the Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula Polymorpha)

Norwalk Gastroenteritis | Norovirus Infections
Icon Genetics GmbH
University Hospital, Ghent

Completed

Recombinant, Bivalent, Norovirus Vaccine Study

Norovirus

Belgium
Takeda

Completed

Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle (VLP) Vaccine in Children

Norovirus

Finland, Panama, Colombia
WCCT Global
Vaxart

Completed

Evaluation of Infectivity and Illness of Norwalk GI.1 Virus Lot 001-09NV in the Human Challenge Model

Norovirus Infection

United States
Takeda

Completed

Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly Population

Norovirus

United States
LigoCyte Pharmaceuticals, Inc.

Completed

Phase 1 Norwalk Vaccine Study

Norovirus

United States
Vaxart

Completed

Safety & Immunogenicity Study of Ad5 Based Oral Norovirus Vaccines (VXA-NVV-103)

Norovirus Infection

United States
Takeda

Completed

Safety and Immunogenicity of Norovirus Bivalent Virus-Like Particle Vaccine in Healthy Adults

Norovirus Prevention

United States
Takeda

Completed

Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP Vaccine (NOR-107)

Healthy Volunteers | Norovirus, Prevention

Belgium
Takeda

Completed

Norovirus Bivalent-Vaccine Efficacy Study

Prevention From Norovirus Infection

United States
Takeda

Completed

Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine

Healthy Participants | Norovirus

United States
Takeda

Completed

Long-Term Immunogenicity of the Norovirus GI.1/GII.4 Bivalent Virus-like Particle (VLP) Vaccine (NoV Vaccine) in Adults

Healthy Volunteers | Norovirus

Belgium, United States
Vaxart

Active, not recruiting

A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy Volunteers

Norovirus Infections

United States
Vaxart

Completed

Ph 1b: Safety & Immunogenicity of Ad5 Based Oral Norovirus Vaccine (VXA-NVV-104)

Norovirus Infections

United States
Vaxart

Completed

A Phase 1, Open-label, Safety and Immunogenicity Study of an Oral Multi-dose Administration Regimen With an Adenoviral-vector Based Tablet Norovirus Vaccine (VXA-G1.1-NN) Administered to Healthy Adult Volunteers ((VXA-G1-1-NN))

Norovirus Infections

United States
Vaxart

Completed

Immunogenicity & Safety Study of Adenovirus Type 5 (AD5) Based Oral Norovirus Vaccines (VXA-NVV-105)

Norovirus Infections

United States
Children's Hospital Medical Center, Cincinnati
LigoCyte Pharmaceuticals, Inc.

Completed

Dose Range Evaluation of Norovirus Challenge Pool (GII.4, CIN-1) (CIN-002)

Norovirus Infections

United States
Romark Laboratories L.C.

Completed

Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children

Rotavirus Infection | Norovirus Infection | Adenoviridae Infection
Vaxart

Completed

Norovirus Challenge Study (G1-1 Challenge)

Norovirus Infections

United States
Chinese University of Hong Kong

Unknown

Identification of Host Factors of Norovirus Infections in Mini-Gut Model

Gastrointestinal Infection

China
Children's Hospital Medical Center, Cincinnati
Mothers' Milk Bank Northeast

Terminated

Human Breastmilk in Young Children With Norovirus Infection of the Gut

Norovirus Infections

United States
Region Zealand

Completed

Admission Pattern Among Children With Gastro-intestinal Infections Before and During the Covid-19 Pandemic

Gastroenteritis | Infectious Disease | Dehydration in Children | COVID-19 Pandemic | Norovirus Infections | Rota Virus Gastroenteritis

Denmark
GlaxoSmithKline

Completed

A Retrospective Survey of the Burden of Rotavirus Gastroenteritis (RV GE) and Nosocomial RV GE in Japan

Rotavirus Gastroenteritis | Nosocomial Rotavirus Gastroenteritis
University Hospital for Infectious Diseases, Croatia

Completed

Enteroadsorbent Polymethylsiloxane vs Probiotic Lactobacillus Reuteri in the Treatment of Rotaviral Gastroenteritis

Rotavirus Gastroenteritis

Croatia
Merck Sharp & Dohme LLC

Completed

A Study of the Immunogenicity, Tolerability, and Safety of a New Formulation of RotaTeq™ in Infants (V260-035)

Rotavirus Gastroenteritis
MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd.
Parexel

Completed

Safety, Reactogenicity and Immunogenicity of Heat-stable Rotavirus Vaccine (HSRV) in Adults and Infants (HSRV)

Rotavirus Gastroenteritis

Bangladesh
PATH
Centers for Disease Control and Prevention; Noguchi Memorial Institute for... and other collaborators

Completed

Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana

Rotavirus Gastroenteritis

Ghana
GlaxoSmithKline

Completed

Estimation of the Burden of Rotavirus Gastroenteritis (RV GE) in Children Less Than 5 Years in Greece

Rotavirus Gastroenteritis

Greece
Shantha Biotechnics Limited

Completed

A Study to Evaluate the Safety of Tetravalent Rotavirus Vaccine in Healthy Indian Adult Male Volunteers

Rotavirus Gastroenteritis

India
Shantha Biotechnics Limited

Unknown

Safety and Immunogenicity Study of the Tetravalent Rotavirus Vaccine

Rotavirus Gastroenteritis

India
Merck Sharp & Dohme LLC

Completed

Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024)

Rotavirus Gastroenteritis
Merck Sharp & Dohme LLC

Completed

ROTATEQ Reexamination Study (V260-037)

Gastroenteritis Rotavirus
Merck Sharp & Dohme LLC

Completed

A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED)

Rotavirus Gastroenteritis
Christian Medical College, Vellore, India
Karolinska Institutet

Completed

Community Based Prevention of Rotavirus Gastroenteritis by a Functional Food Supplement

Rotavirus Gastroenteritis

India
GlaxoSmithKline

Completed

Study to Evaluate the Effectiveness of Rotarix™ Against Severe Gastroenteritis Among Hospitalized Children in Brazil

Rotavirus Gastroenteritis

Brazil
University of Chile
Bharat Biotech International Limited

Recruiting

The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E

Rotavirus Gastroenteritis

Chile
PT Bio Farma

Completed

Efficacy, Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in Neonates

Rotavirus Gastroenteritis

Indonesia
Bharat Biotech International Limited

Completed

Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac in Healthy Infants in Vietnam

Rotavirus Gastroenteritis

Vietnam
Lifespan
Merck Sharp & Dohme LLC

Completed

Rotavirus Gastroenteritis and Vaccine Usage in Rhode Island

Rotavirus Gastroenteritis

United States
Serum Institute of India Pvt. Ltd.
PATH

Completed

Phase III Study on Rotavirus Vaccine to Evaluate Lot-to-lot Consistency and Interference With Routine UIP Immunization

Rotavirus Gastroenteritis

India

Clinical Trials on Norovirus Gastroenteritis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations